ENvue Medical Statistics
Total Valuation
ENvue Medical has a market cap or net worth of $3.82 million. The enterprise value is $4.04 million.
| Market Cap | 3.82M |
| Enterprise Value | 4.04M |
Important Dates
The last earnings date was Monday, August 17, 2026, after market close.
| Earnings Date | Aug 17, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ENvue Medical has 11.08 million shares outstanding. The number of shares has increased by 1,813.02% in one year.
| Current Share Class | 11.08M |
| Shares Outstanding | 11.08M |
| Shares Change (YoY) | +1,813.02% |
| Shares Change (QoQ) | +87.20% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 2.66% |
| Float | 11.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.98 |
| Forward PS | n/a |
| PB Ratio | 0.09 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.10 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.66, with a Debt / Equity ratio of 0.04.
| Current Ratio | 0.66 |
| Quick Ratio | 0.22 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -59.14% and return on invested capital (ROIC) is -25.26%.
| Return on Equity (ROE) | -59.14% |
| Return on Assets (ROA) | -20.99% |
| Return on Invested Capital (ROIC) | -25.26% |
| Return on Capital Employed (ROCE) | -48.53% |
| Weighted Average Cost of Capital (WACC) | 8.68% |
| Revenue Per Employee | $137,571 |
| Profits Per Employee | -$3.51M |
| Employee Count | 14 |
| Asset Turnover | 0.04 |
| Inventory Turnover | 1.01 |
Taxes
| Income Tax | -353,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -94.08% in the last 52 weeks. The beta is 1.35, so ENvue Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.35 |
| 52-Week Price Change | -94.08% |
| 50-Day Moving Average | 0.44 |
| 200-Day Moving Average | 1.76 |
| Relative Strength Index (RSI) | 36.13 |
| Average Volume (20 Days) | 1,631,707 |
Short Selling Information
The latest short interest is 344,075, so 3.10% of the outstanding shares have been sold short.
| Short Interest | 344,075 |
| Short Previous Month | 74,962 |
| Short % of Shares Out | 3.10% |
| Short % of Float | 3.10% |
| Short Ratio (days to cover) | 0.25 |
Income Statement
In the last 12 months, ENvue Medical had revenue of $1.93 million and -$49.19 million in losses. Loss per share was -$17.24.
| Revenue | 1.93M |
| Gross Profit | -502,000 |
| Operating Income | -15.09M |
| Pretax Income | -21.42M |
| Net Income | -49.19M |
| EBITDA | -14.14M |
| EBIT | -15.09M |
| Loss Per Share | -$17.24 |
Balance Sheet
The company has $1.08 million in cash and $1.31 million in debt, with a net cash position of -$226,000 or -$0.02 per share.
| Cash & Cash Equivalents | 1.08M |
| Total Debt | 1.31M |
| Net Cash | -226,000 |
| Net Cash Per Share | -$0.02 |
| Equity (Book Value) | 30.76M |
| Book Value Per Share | 3.75 |
| Working Capital | -2.49M |
Cash Flow
In the last 12 months, operating cash flow was -$11.65 million and capital expenditures -$95,000, giving a free cash flow of -$11.74 million.
| Operating Cash Flow | -11.65M |
| Capital Expenditures | -95,000 |
| Depreciation & Amortization | 951,000 |
| Net Borrowing | -1.00M |
| Free Cash Flow | -11.74M |
| FCF Per Share | -$1.06 |
Margins
| Gross Margin | -26.06% |
| Operating Margin | -783.59% |
| Pretax Margin | -1,111.94% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ENvue Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1,813.02% |
| Shareholder Yield | -1,813.02% |
| Earnings Yield | -1,288.10% |
| FCF Yield | -307.54% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 12, 2025. It was a reverse split with a ratio of 1:10.
| Last Split Date | Aug 12, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
ENvue Medical has an Altman Z-Score of -5.58 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.58 |
| Piotroski F-Score | 1 |